Scholarlink

Background <p>Glucosamine, a naturally occurring amino sugar abundant in cartilage, has long been utilized as a dietary supplement to alleviate osteoarthritis (OA) and joint pain. Beyond its structural role in maintaining joint integrity, glucosamine is metabolized through the hexosamine biosynthetic pathway (HBP) to generate UDP-N-acetylglucosamine (UDP-GlcNAc), the indispensable donor substrate for protein <i>O</i>-linked N-acetylglucosamine (<i>O</i>-GlcNAc) modification. </p> Findings <p>Accumulating evidence indicates that glucosamine-driven modulation of HBP flux and the consequent alteration of <i>O</i>-GlcNAcylation exert profound effects on cellular signaling, metabolic regulation, and inflammatory responses. These mechanisms extend far beyond musculoskeletal health, influencing the pathogenesis of diverse conditions such as rheumatoid arthritis (RA), diabetes, obesity, neuroinflammation, neurodegenerative disorders, sepsis, and cancer. Despite glucosamine’s long-standing clinical use, its potential role as a metabolic regulator of <i>O</i>-GlcNAc cycling remains underexplored. </p> Conclusion <p>This review integrates current insights into the molecular basis of glucosamine-enhanced <i>O</i>-GlcNAcylation, highlighting its implications for disease onset and progression, and proposing a broader therapeutic framework that positions glucosamine as a promising modulator of inflammation and systemic pathology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Glucosamine as a regulator of O-GlcNAc signaling: linking metabolism to disease pathogenesis

  • 期刊论文

  • 发表日期：

    2026年3月17日

查看全文
  • Sang-Min Kim,
  • Chanhaeng Lee,
  • Dong Yeol Kim,
  • Inn-Oc Han

摘要

Background

Glucosamine, a naturally occurring amino sugar abundant in cartilage, has long been utilized as a dietary supplement to alleviate osteoarthritis (OA) and joint pain. Beyond its structural role in maintaining joint integrity, glucosamine is metabolized through the hexosamine biosynthetic pathway (HBP) to generate UDP-N-acetylglucosamine (UDP-GlcNAc), the indispensable donor substrate for protein O-linked N-acetylglucosamine (O-GlcNAc) modification.

Findings

Accumulating evidence indicates that glucosamine-driven modulation of HBP flux and the consequent alteration of O-GlcNAcylation exert profound effects on cellular signaling, metabolic regulation, and inflammatory responses. These mechanisms extend far beyond musculoskeletal health, influencing the pathogenesis of diverse conditions such as rheumatoid arthritis (RA), diabetes, obesity, neuroinflammation, neurodegenerative disorders, sepsis, and cancer. Despite glucosamine’s long-standing clinical use, its potential role as a metabolic regulator of O-GlcNAc cycling remains underexplored.

Conclusion

This review integrates current insights into the molecular basis of glucosamine-enhanced O-GlcNAcylation, highlighting its implications for disease onset and progression, and proposing a broader therapeutic framework that positions glucosamine as a promising modulator of inflammation and systemic pathology.